Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Most cancers evolve over time as patients initially responsive to therapy acquire resistance to the same drugs at relapse. Cancer stem cells have been postulated to represent a therapy-refractory reservoir for relapse, but formal proof of this model is lacking. We prospectively characterized leukemi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood
Hauptverfasser: Ho, Tzu-Chieh, LaMere, Mark, Stevens, Brett M., Ashton, John M., Myers, Jason R., O’Dwyer, Kristen M., Liesveld, Jane L., Mendler, Jason H., Guzman, Monica, Morrissette, Jennifer D., Zhao, Jianhua, Wang, Eunice S., Wetzler, Meir, Jordan, Craig T., Becker, Michael W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2016
Schlagworte:
Plenary Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5043124/
https://ncbi.nlm.nih.gov/pubmed/27421961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-02-695312
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge